Atlas Trials

Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

Clinical trial NCT06980623 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06980623
Sponsor
Brigham and Women's Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Type 2 DiabetesHeart Failure
Start date
2025-01-01
Primary completion
2025-11-30
Enrollment
26000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.